Drug Profile
Esprolol
Latest Information Update: 25 Jun 2001
Price :
$50
*
At a glance
- Originator Selectus Pharmaceuticals [CEASED]
- Class Antiarrhythmics; Propanolamines; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Anxiety disorders; Migraine
Most Recent Events
- 25 Jun 2001 Discontinued-II for Angina pectoris in USA (Sublingual)
- 25 Jun 2001 Discontinued-II for Anxiety disorders in USA (Sublingual)
- 25 Jun 2001 Discontinued-II for Migraine in USA (Sublingual)